142 related articles for article (PubMed ID: 7672675)
1. Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting.
Xia HX; Windle HJ; Marshall DG; Smyth CJ; Keane CT; O'Morain CA
Gut; 1995 Jul; 37(1):30-4. PubMed ID: 7672675
[TBL] [Abstract][Full Text] [Related]
2. DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Nada T; Ando T; Nobata K; Tsuzuki T; Minami M; Ina K; Iinuma Y; Ichiyama S; Ohta M; El-Omar E; Kusugami K; Goto H
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():39-47. PubMed ID: 15298604
[TBL] [Abstract][Full Text] [Related]
3. Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting.
Taylor NS; Fox JG; Akopyants NS; Berg DE; Thompson N; Shames B; Yan L; Fontham E; Janney F; Hunter FM
J Clin Microbiol; 1995 Apr; 33(4):918-23. PubMed ID: 7790461
[TBL] [Abstract][Full Text] [Related]
4. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy.
Soto G; Bautista CT; Roth DE; Gilman RH; Velapatiño B; Ogura M; Dailide G; Razuri M; Meza R; Katz U; Monath TP; Berg DE; Taylor DN;
J Infect Dis; 2003 Nov; 188(9):1263-75. PubMed ID: 14593583
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
7. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
[TBL] [Abstract][Full Text] [Related]
8. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Iser JH; Buttigieg RJ; Iseli A
Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.
Bell GD; Powell KU
Scand J Gastroenterol Suppl; 1996; 215():96-104. PubMed ID: 8722391
[TBL] [Abstract][Full Text] [Related]
10. Reinfection rate following effective therapy against Helicobacter pylori infection in Japan.
Adachi M; Mizuno M; Yokota K; Miyoshi M; Nagahara Y; Maga T; Ishiki K; Inaba T; Okada H; Oguma K; Tsuji T
J Gastroenterol Hepatol; 2002 Jan; 17(1):27-31. PubMed ID: 11987263
[TBL] [Abstract][Full Text] [Related]
11. Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis.
Burucoa C; Lhomme V; Fauchere JL
J Clin Microbiol; 1999 Dec; 37(12):4071-80. PubMed ID: 10565934
[TBL] [Abstract][Full Text] [Related]
12. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
Tepes B; Kavcic B; Gubina M; Krizman I
Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
[TBL] [Abstract][Full Text] [Related]
13. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation.
Andreson H; Sillakivi T; Peetsalu M; Peetsalu A; Mikelsaar M
Scand J Gastroenterol; 2007 Mar; 42(3):324-9. PubMed ID: 17354111
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.
Borody TJ; Andrews P; Fracchia G; Brandl S; Shortis NP; Bae H
Gut; 1995 Oct; 37(4):477-81. PubMed ID: 7489931
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Sung JJ; Chung SC; Ling TK; Yung MY; Leung VK; Ng EK; Li MK; Cheng AF; Li AK
N Engl J Med; 1995 Jan; 332(3):139-42. PubMed ID: 7800005
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of Helicobacter pylori populations in antral biopsies from individual patients using randomly amplified polymorphic DNA (RAPD) fingerprinting.
Marshall DG; Chua A; Keeling PW; Sullivan DJ; Coleman DC; Smyth CJ
FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):317-23. PubMed ID: 7773249
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Helicobacter pylori strainsisolated before and after therapy.
Andrzejewska E; Szkaradkiewicz A; Klincewicz H; Linke K
Med Sci Monit; 2003 Sep; 9(9):CR400-4. PubMed ID: 12960930
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori detection in Chinese subjects: a comparison of two common DNA fingerprinting methods.
Yakoob J; Hu G; Fan X; Zhang Z
Br J Biomed Sci; 2001; 58(4):239-43. PubMed ID: 11788001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
